Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistance of Anti-HPV After a Single Dose of Gardasil and the Effect of a Dose of Gardasil-9 When Administered 3-8 Years Later

NCT03431246 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT03431246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistance of Anti-HPV After a Single Dose of Gardasil and the Effect of a Dose of Gardasil-9 When Administered 3-8 Years Later
Lead sponsor
Laval University
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2016
Completion date
December 5, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus vaccines